Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Imaging Study Reveals a Clue to Schizophrenia

By HospiMedica staff writers
Posted on 08 Jan 2001
A magnetic resonance (MR) brain imaging study has revealed that the thalamus, the brain's main sensory filter, is smaller than normal from the earliest stages of schizophrenia. More...
The study, conducted by researchers at the Institute of Psychiatry (London, UK), was published in the January issue of the American Journal of Psychiatry.

The thalamus is of particular interest in schizophrenia because it is the area of the brain where information is received and relayed to other areas. It receives information by way of the senses, which is then filtered and passed to the proper regions for processing. Schizophrenia patients often have difficulty in processing information properly and, as a result, may experience brain overload in some areas.

The study involved 67 participants, of whom 38 were experiencing their first episode of psychosis and 29 were healthy volunteers. In contrast to other studies, 13 of the schizophrenia patients had no or little experience of antipsychotic medication. MRI scans identified differences in the thalamus between the two groups. The results showed that even in the earliest stages of schizophrenia, the thalamus was smaller than in healthy people. The researchers say these findings along with other findings that schizophrenia patients have decreased gray matter at the earliest stages of the illness suggest a role for brain imaging to pinpoint warning signs of illness and perhaps even prevent its development.

"This study reveals that there is a fundamental problem in the hub of the brain,” says Dr. Tonmoy Sharma, leader of the study. "If you think of the brain in terms of networks, it is like making a phone call when the line is not connected properly. The call can't be made, or you may get through to the wrong person. It is the same in the brain.”

New
Gold Member
Neonatal Heel Incision Device
Tenderfoot
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
New
Blood Gas Analyzer
i-Check200
New
Rapid Sepsis Test
SeptiCyte RAPID
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: Allevion Medical receives FDA Clearance for Vantage, introducing a fully disposable approach to minimally invasive spinal decompression (photo courtesy of Allevion Medical)

Single-Use System Enables Minimally Invasive Decompression for Lumbar Spinal Stenosis

Lumbar spinal stenosis is frequently driven by hypertrophic bone that narrows the canal and produces pain. Conventional decompression often relies on larger incisions and bulky retractors, adding time,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.